Three New Square Intellectual Property

Three New Square Intellectual Property

Show options

England

Barristers

Thomas Lunt

Position

Thomas’ practice concerns all areas of intellectual property including patents and SPCs, trade marks and passing off, copyright, and confidential information. 

His recent work in pharmaceutical and life sciences patents includes AstraZeneca v Glenmark (the most recent appellate decision concerning preliminary injunctions in the pharmaceutical field, and the most recent concerning plausibility), Sandoz, Teva v BMS (the first appellate decision on plausibility following G2/21) and Accord v Astellas (a significant obviousness appeal concerning the molecule enzalutamide). 

Representative of his work in FRAND and economic disputes, Thomas acted in the Panasonic v Xiaomi, Lenovo v Ericsson litigation, TP-Link v Huawei, and Amazon v InterDigital, and in Dr Reddy’s, NHS England & ors v Warner-Lambert (the pregabalin damages inquiry).

Career

2019-2020: 12-month pupillage at Three New Square to Miles Copeland, Jeremy Heald, Joe Delaney, Stuart Baran and Geoffrey Pritchard 2018-2019: Legal Assistant at Carpmaels & Ransford LLP. Involved in a pharmaceutical patents matter relating to anti-CGRP antibodies for the treatment of migraine. 2018: Called to the Bar, Lincoln’s Inn

Education

2017-2018:      BPTC at BPP Birmingham: Outstanding; 1st in cohort 2016-2017:      GDL at BPP Birmingham: Distinction 2012-2016:      MChem Chemistry at Lincoln College, Oxford: 1st class  

Mentions

Content supplied by Three New Square Intellectual Property